Sana Biotechnology, Inc. SEC filings SANA
Sana Biotechnology, Inc. has 389 filings in SEC EDGAR's recent list, going back to Jun 26, 2020. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 8, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Sep 8, 2026 | Sep 8, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2026 | Aug 10, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 5, 2026 | Jun 4, 2026 |
| 8-K |
Current report
Other events
|
May 15, 2026 | May 15, 2026 |
| 8-K |
Current report
Results of operations
|
May 11, 2026 | May 11, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 24, 2026 | Apr 22, 2026 |
| 8-K |
Current report
Other events
|
Apr 13, 2026 | Apr 10, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
Mar 3, 2026 | Mar 3, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Feb 17, 2026 | Feb 17, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 14, 2026 | Jan 14, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Officer or director change, Other events
|
Sep 5, 2025 | Sep 4, 2025 |
| 8-K |
Current report
Officer or director change
|
Aug 29, 2025 | Aug 28, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2025 | Aug 11, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Aug 7, 2025 | Aug 6, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 6, 2025 | Aug 6, 2025 |
| 8-K |
Current report
Other events
|
Jun 23, 2025 | Jun 23, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 6, 2025 | Jun 5, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
May 8, 2025 | May 8, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 17, 2025 | Mar 17, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2024 | Nov 8, 2024 |
| 8-K |
Current report
Officer or director change
|
Oct 8, 2024 | Oct 4, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 12, 2024 | Sep 6, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 7, 2024 | Jun 6, 2024 |
| 8-K |
Current report
Results of operations
|
May 8, 2024 | May 8, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 18, 2024 | Apr 18, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 29, 2024 | Feb 29, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Feb 8, 2024 | Feb 7, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Feb 7, 2024 | Feb 7, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 9, 2024 | Jan 9, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 11, 2023 | Dec 11, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2023 | Nov 8, 2023 |
| 8-K |
Current report
Exit or restructuring costs, Regulation FD disclosure
|
Oct 10, 2023 | Oct 10, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 13, 2023 | Sep 12, 2023 |
| 8-K |
Current report
Agreement ended
|
Aug 21, 2023 | Aug 17, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2023 | Aug 3, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 9, 2023 | Jun 8, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 7, 2023 | Jun 7, 2023 |
| 8-K |
Current report
Results of operations
|
May 8, 2023 | May 8, 2023 |
| 8-K |
Current report
Officer or director change
|
Apr 28, 2023 | Apr 28, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 10, 2023 | Apr 10, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 16, 2023 | Mar 16, 2023 |
| 8-K |
Current report
Other events
|
Jan 26, 2023 | Jan 26, 2023 |
| 8-K |
Current report
Other events
|
Jan 26, 2023 | Jan 26, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 10, 2023 | Jan 10, 2023 |
| 8-K |
Current report
Exit or restructuring costs
|
Nov 29, 2022 | Nov 29, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 2, 2022 | Nov 2, 2022 |
| 8-K | Current report | Nov 1, 2022 | Oct 27, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2022 | Aug 4, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 14, 2022 | Jun 14, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 9, 2022 | Jun 6, 2022 |
| 8-K |
Current report
Material agreement, New debt, Other events
|
Jun 1, 2022 | Jun 1, 2022 |
| 8-K |
Current report
Results of operations
|
May 10, 2022 | May 10, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 16, 2022 | Mar 16, 2022 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Jan 11, 2022 | Jan 7, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2021 | Nov 8, 2021 |
| 8-K |
Current report
Material agreement, Other events
|
Oct 19, 2021 | Oct 15, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 13, 2021 | Sep 13, 2021 |
| 8-K |
Current report
Officer or director change
|
Sep 3, 2021 | Sep 1, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2021 | Aug 4, 2021 |
| 8-K |
Current report
Material agreement, New debt
|
Jul 14, 2021 | Jul 13, 2021 |
| 8-K |
Current report
Results of operations
|
May 5, 2021 | May 5, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 24, 2021 | Mar 24, 2021 |
| 8-K |
Current report
Officer or director change
|
Mar 2, 2021 | Feb 24, 2021 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Feb 9, 2021 | Feb 8, 2021 |
Showing 67 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- SANA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Seattle, WA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1770121
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.